Searchable abstracts of presentations at key conferences in endocrinology

ea0026p510 | Bone/calcium/Vitamin D | ECE2011

Calcium homeostasis in diabetic postmenopausal women with bone fracture

Gusova A A , Pavlova M G , Melnichenko G A , Kavalersky G M , Silin L L , Zaitseva N V

Background and aims: The aim was to compare calcium homeostasis indexes in diabetic and non-diabetic patients with or without fractures.Materials and methods: We examined 62 postmenopausal women with type 2 diabetes mellitus (DM), 32 of them had bone fracture within last month. The control group included 54 non-diabetic women, 25 within a group were recently fractured. Groups were comparable in body mass index, age, duration of menopause and calcium inta...

ea0026p528 | Bone/calcium/Vitamin D | ECE2011

Diabetes mellitus and the incidence of fracture

Gusova A A , Pavlova M G , Melnichenko G A , Kavalersky G M , Silin L L , Zaitseva N V

Objective: To study if people with diabetes mellitus (DM) have increased risk of fracture.Methods: The study population consisted of 29 512 people aged 50 years or more. There were 1981 diabetic patients among them. The records of the local trauma clinic for two-year period were analyzed.Results: Women with DM had fewer fractures during two years than women without DM (relative risk 0.43; 95% confidence interval 0.30–0.61). Th...

ea0026p705 | Diabetes complications | ECE2011

Diabetes mellitus and risk of fracture

Gusova A A , Pavlova M G , Melnichenko G A , Kavalersky G M , Silin L L , Sountsov Yu I

Objective: To examine association between diabetes properties (type, duration, treatment regiment etc.) and risk of any fracture in diabetic population.Methods: We analyzed local trauma clinic data for 3 sequential years from 2662 diabetic persons who were entered The National Register of diabetes mellitus patients (133 subjects with type 1 diabetes mellitus (T1DM) and 1995 ones with T2DM).Results: Fracture risk was higher in T1DM ...

ea0029p135 | Bone & Osteoporosis | ICEECE2012

Bone mineral density in diabetic postmenopausal women with bone fracture

Gusova A. , Pavlova M. , Melnichenko G. , Kavalersky G.

Introduction: There are contradicting data about bone mineral density (BMD) in patients with type 2 diabetes mellitus (DM), although most studies describe increased BMD values in them. Due to this finding it is not clear how tightly bone fragility is bound with BMD in type 2 diabetic people.Design: We provided dual-energy X-ray absorptiometry of lumbar spine and proximal femur to 46 postmenopausal women with type 2 diabetes mellitus (DM), 14 of them had ...

ea0029p517 | Diabetes | ICEECE2012

Fracture predictors in diabetic postmenopausal women without hyperparathyroidism

Gusova A. , Pavlova M. , Melnichenko G. , Kavalersky G.

Introduction: The diabetes mellitus (DM) is the known risk factor of fractures. The aim was to determine predictors of fractures in type 2 diabetic postmenopausal women without hyperparathyroidism.Design: We analyzed local trauma clinic data for 3 sequential years from 2 662 diabetic persons who were entered The National Register of diabetes mellitus patients (133 subjects with type 1 diabetes mellitus and 1995 ones with type 2 DM). Afterward we examined...

ea0029p525 | Diabetes | ICEECE2012

Psychoemotional state of diabetic women with fracture

Gusova A. , Pavlova M. , Melnichenko G. , Kavalersky G.

Background and aims: The aim was to determine psychoemotional state in diabetic and non-diabetic patients with or without fractures and its correlation with bone condition.Materials and methods: We examined 62 postmenopausal women with type 2 diabetes mellitus (DM), 29 of them had bone fracture within last month. The control group included 56 non-diabetic women, 26 within a group were recently fractured. Groups were comparable in body mass index, age, du...

ea0029p348 | Clinical case reports - Pituitary/Adrenal | ICEECE2012

A clinical case of a 21 years old man with inborn pituitary dystopia

Sorkina E. , Poteshkin Y. , Pronin V. , Melnichenko G. , Pavlova M. , Likhodey N.

A 21 years old man had growth failure since 11 y.o., micropenis, high-pitched voice, the absence of secondary sex characteristics and male sexual behavior, constant fatigue and weakness. The boy was born in time after 1st normal pregnancy, birth weight 3000 g, length 57 cm, had unilateral cryptorchidism (surgical treatment in 2002). At the age of 21 the height of the patient was 144 cm (SDS - 4.62), BMI 15 kg/m2 (BMI SDS −3.89), Tanner G1P1, bone age 13 y.o. I...

ea0029p937 | Female Reproduction | ICEECE2012

Hypoandrogenemia at women with hypogonadotropic hypogonadism

Ilovayskaya I. , Zekster V. , Mikhaylova D. , Goncharov N. , Melnichenko G. , Dedov I.

We estimated androgen status at 111 female patients (pts) with HH before and after hormonal therapy (HT) by estadiol 2 mg+dydrogesterone 10 mg in sequence manner not <12 months. Median age of pts was 28 y.o., mean duration of HH 6.2 year, isolated HH n=56 group 1, HH as a part of hypopituitarism n=55 group 2, 45 healthy women of the same age were included in control group. Total T, SHBG and DHEA-S levels were measured, free T levels were calculated using stan...

ea0029p1236 | Obesity | ICEECE2012

Effect of orlistat in Russian adolescents with metabolic syndrome: a randomized controlled trial

Melnichenko G. , Peterkova V. , Savelyeva L. , Zubkova N. , Vasyukova O. , Kosygina A.

Background: Metabolic syndrome (MS) in children is associated with future risk of developing type 2 diabetes mellitus and cardiovascular disease in adults. In the pediatric population lifestyle interventions alone are often insufficient.Objective: To evaluate the efficacy and safety of orlistat in obese adolescents with MS.Design: A 6 month open, comparative, randomized study of 60 obese adolescents (aged 12–17 years; mean bod...

ea0026p32 | Adrenal cortex | ECE2011

Mission study: an international observational study on the mortality in Cushing’s syndrome

Pivonello R , Melnichenko G , Zacharieva S , Gu F , Oscar B , Shah N S , Gaillard R , Colao A

Cushing’s syndrome (CS) is a rare but severe disease associated with an increased mortality especially due to cardiovascular diseases, and associated with various systemic complications, including hypertension, glucose intolerance or diabetes mellitus, dyslipidemia and coagulopathy. Few studies have systematically evaluated the mortality of CS in a large and worldwide population of CS. The MISSION study is a retrospective study aimed at assessing the mortality in a large ...